MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Clinical trials for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody tested in fight against tough blood cancers
Disease control OngoingThis early-stage study is testing a new antibody drug called Hu8F4 in patients with advanced blood cancers like leukemia and myelodysplastic syndrome (MDS) that have not responded to other treatments. The main goals are to find the safest and most effective dose and to understand…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 01:28 UTC
-
Race to find better treatment for aggressive blood disorders
Disease control OngoingThis study aims to find the most effective drug combination for treating higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), which are serious blood and bone marrow disorders. Researchers are comparing a standard chemotherapy drug (azacitidine)…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC